Editor's Picks

There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.

Genentech, Inc.

Genentech, Inc.

  1. Roche Bids $43.7B For Genentech - July 22
    YouTube Logo YouTube 16 months ago
  2. Heroes of Hope
    YouTube Logo YouTube 33 months ago
  3. Another Hope: Rheumatoid Arthritis Infusion Therapy (2008)
    YouTube Logo YouTube 13 months ago
  4. Popular sentiment indicators and how to use them.
    YouTube Logo YouTube 19 months ago
  5. FDA APPROVES HERCEPTIN® FOR THE ADJUVANT TREATMENT OF
    YouTube Logo YouTube 21 months ago
  6. Why the Jeans You Wear Can Make a Difference
    YouTube Logo YouTube 38 months ago
(What's this?)
  1. Are you a Publisher?

    We built Daylife.com using our SmartMedia Services platform, which can give you thousands of content-rich, advertiser-friendly pages (like this one) on any topic and with full editorial control. Learn More »

    Our Customers
    prev
    next
  2. Our Products
    Daylife Select

    A point & click tool to create dynamic content portals. Learn More »

  3. Daylife API

    Unlimited smart, customizable content to suit any publisher. Learn More »

  4. Enterprise API

    Use the Daylife Platform to distribute content across your sites. Learn More »

  5. SmartContext

    Weave the web's best content into your own. Learn More »

About Genentech, Inc.

Wikipedia

There are no results for this module. Edit this module to change the search term used to query Wikipedia

Related Photos

Genentech headquarters in South San Francisco, Calif. seen Friday, March 6, 2009.
Pause Play 1/25
prev
  1. In this July 10, 2006 file photo, Genentech researcher Mark Nagel works on an experiment in a research laboratory at Genentech headquarters in a South San Francisco, Calif. AP Photo logo AP Photo 9 months ago

    In this July 10, 2006 file photo, Genentech researcher Mark Nagel works on an experiment in a research laboratory at Genentech headquarters in a South San Francisco, Calif.

    View Photo »
  2. Genentech headquarters in South San Francisco, Calif. seen Friday, March 6, 2009. AP Photo logo AP Photo 9 months ago

    Genentech headquarters in South San Francisco, Calif. seen Friday, March 6, 2009.

    View Photo »
  3. Genentech headquarters in South San Francisco, Calif. seen Friday, March 6, 2009. AP Photo logo AP Photo 9 months ago

    Genentech headquarters in South San Francisco, Calif. seen Friday, March 6, 2009.

    View Photo »
  4. Genentech headquarters in South San Francisco, Calif. seen Friday, March 6, 2009. AP Photo logo AP Photo 9 months ago

    Genentech headquarters in South San Francisco, Calif. seen Friday, March 6, 2009.

    View Photo »
  5. Exterior view of Genentech headquarters in South San Francisco, Calif. , Friday, March 6, 2009. AP Photo logo AP Photo 9 months ago

    Exterior view of Genentech headquarters in South San Francisco, Calif. , Friday, March 6, 2009.

    View Photo »
  6. Todd Pierce, Genentech Inc.'s chief technology officer, poses for a photo with some of his employees in the company's headquarters in San Francisco, Friday, Dec. 12, 2008. AP Photo logo AP Photo 12 months ago

    Todd Pierce, Genentech Inc.'s chief technology officer, poses for a photo with some of his employees in the company's headquarters in San Francisco, Friday, Dec. 12, 2008.

    View Photo »
  7. Todd Pierce, Genentech Inc.'s chief technology officer, poses for a photo in the company's headquarters in San Francisco, Friday, Dec. 12, 2008. AP Photo logo AP Photo 12 months ago

    Todd Pierce, Genentech Inc.'s chief technology officer, poses for a photo in the company's headquarters in San Francisco, Friday, Dec. 12, 2008.

    View Photo »
  8. A general view shows the plant of Swiss pharmaceutical company Roche and the Rhine River in Basel July 20, 2009. Swiss drugmaker Roche gave a bullish forecast for the next two years after its $47 billion acquisition of Genentech and said it would expand capacity for H1N1 flu drug Tamiflu. Reuters Pictures 4 months ago

    A general view shows the plant of Swiss pharmaceutical company Roche and the Rhine River in Basel July 20, 2009. Swiss drugmaker Roche gave a bullish forecast for the next two years after its $47 billion acquisition of Genentech and said it would expand capacity for H1N1 flu drug Tamiflu.

    View Photo »
  9. The logo of Swiss pharmaceutical company Roche is seen at an office building at the company's plant in Basel July 20, 2009. Reuters Pictures 4 months ago

    The logo of Swiss pharmaceutical company Roche is seen at an office building at the company's plant in Basel July 20, 2009.

    View Photo »
  10. A general view shows the plant of Swiss pharmaceutical company Roche and the Rhine River in Basel July 20, 2009. Swiss drugmaker Roche gave a bullish forecast for the next two years after its $47 billion acquisition of Genentech and said it would expand capacity for H1N1 flu drug Tamiflu. Reuters Pictures 4 months ago

    A general view shows the plant of Swiss pharmaceutical company Roche and the Rhine River in Basel July 20, 2009. Swiss drugmaker Roche gave a bullish forecast for the next two years after its $47 billion acquisition of Genentech and said it would expand capacity for H1N1 flu drug Tamiflu.

    View Photo »
  11. A general view shows the plant of Swiss pharmaceutical company Roche and the Rhine River in Basel July 20, 2009. Swiss drugmaker Roche gave a bullish forecast for the next two years after its $47 billion acquisition of Genentech and said it would expand capacity for H1N1 flu drug Tamiflu. Reuters Pictures 4 months ago

    A general view shows the plant of Swiss pharmaceutical company Roche and the Rhine River in Basel July 20, 2009. Swiss drugmaker Roche gave a bullish forecast for the next two years after its $47 billion acquisition of Genentech and said it would expand capacity for H1N1 flu drug Tamiflu.

    View Photo »
  12. The Aug. 12, 2005 file photo shows the logo of Swiss pharmaceutical company Roche at the headquarters in Basel, Switzerland. AP Photo logo AP Photo 9 months ago

    The Aug. 12, 2005 file photo shows the logo of Swiss pharmaceutical company Roche at the headquarters in Basel, Switzerland.

    View Photo »
  13. General view of Swiss pharmaceutical company Roche's general annual shareholders meeting in Basel March 10, 2009. Reuters Pictures 9 months ago

    General view of Swiss pharmaceutical company Roche's general annual shareholders meeting in Basel March 10, 2009.

    View Photo »
  14. Franz Humer (L), chairman of the board and Severin Schwan, CEO of the Swiss pharmaceutical company Roche, speak before the company's general annual shareholders meeting in Basel March 10, 2009. Reuters Pictures 9 months ago

    Franz Humer (L), chairman of the board and Severin Schwan, CEO of the Swiss pharmaceutical company Roche, speak before the company's general annual shareholders meeting in Basel March 10, 2009.

    View Photo »
  15. Franz Humer, chairman of the board of the Swiss pharmaceutical company Roche, holds a speech during the company's general annual shareholders meeting in Basel March 10, 2009. Reuters Pictures 9 months ago

    Franz Humer, chairman of the board of the Swiss pharmaceutical company Roche, holds a speech during the company's general annual shareholders meeting in Basel March 10, 2009.

    View Photo »
  16. Severin Schwan, CEO of the Swiss pharmaceutical company Roche, attends the company's general annual shareholders meeting in Basel March 10, 2009. Reuters Pictures 9 months ago

    Severin Schwan, CEO of the Swiss pharmaceutical company Roche, attends the company's general annual shareholders meeting in Basel March 10, 2009.

    View Photo »
  17. Severin Schwan, CEO of the Swiss pharmaceutical company Roche, attends the company's general annual shareholders meeting in Basel March 10, 2009. Reuters Pictures 9 months ago

    Severin Schwan, CEO of the Swiss pharmaceutical company Roche, attends the company's general annual shareholders meeting in Basel March 10, 2009.

    View Photo »
  18. Severin Schwan, CEO of the Swiss pharmaceutical company Roche, attends the company's general annual shareholders meeting in Basel March 10, 2009. Reuters Pictures 9 months ago

    Severin Schwan, CEO of the Swiss pharmaceutical company Roche, attends the company's general annual shareholders meeting in Basel March 10, 2009.

    View Photo »
  19. Franz Humer (L) chairman of the board and Severin Schwan, CEO of the Swiss pharmaceutical company Roche, attends the company's general annual shareholders meeting in Basel March 10, 2009. Reuters Pictures 9 months ago

    Franz Humer (L) chairman of the board and Severin Schwan, CEO of the Swiss pharmaceutical company Roche, attends the company's general annual shareholders meeting in Basel March 10, 2009.

    View Photo »
  20. Franz Humer, chairman of the board of the Swiss pharmaceutical company Roche, attends the company's general annual shareholders meeting in Basel March 10, 2009. Reuters Pictures 9 months ago

    Franz Humer, chairman of the board of the Swiss pharmaceutical company Roche, attends the company's general annual shareholders meeting in Basel March 10, 2009.

    View Photo »
  21. Franz Humer, chairman of the board of the Swiss pharmaceutical company Roche, attends the company's general annual shareholders meeting in Basel March 10, 2009. Reuters Pictures 9 months ago

    Franz Humer, chairman of the board of the Swiss pharmaceutical company Roche, attends the company's general annual shareholders meeting in Basel March 10, 2009.

    View Photo »
  22. Bill Burns, CEO Division of Roche Pharmaceuticals, speaks during an interview in New York February 6, 2009. Reuters Pictures 10 months ago

    Bill Burns, CEO Division of Roche Pharmaceuticals, speaks during an interview in New York February 6, 2009.

    View Photo »
  23. Severin Schwan, CEO of Roche, speaks during an interview with The Associated Press Friday, Feb. 6, 2009, in New York. AP Photo logo AP Photo 10 months ago

    Severin Schwan, CEO of Roche, speaks during an interview with The Associated Press Friday, Feb. 6, 2009, in New York.

    View Photo »
  24. Severin Schwan, CEO of Roche, speaks during an interview with The Associated Press Friday, Feb. 6, 2009, in New York. AP Photo logo AP Photo 10 months ago

    Severin Schwan, CEO of Roche, speaks during an interview with The Associated Press Friday, Feb. 6, 2009, in New York.

    View Photo »
  25. Severin Schwan, CEO of Roche, speaks during an interview with The Associated Press Friday, Feb. 6, 2009, in New York. AP Photo logo AP Photo 10 months ago

    Severin Schwan, CEO of Roche, speaks during an interview with The Associated Press Friday, Feb. 6, 2009, in New York.

    View Photo »
next
AP Photo logo AP Photo 9 months ago

Genentech headquarters in South San Francisco, Calif. seen Friday, March 6, 2009.

View Photo »
View All »

Related Topics

  1. US Food and Drug Administration US Food and Drug Administration
  2. Biogen Idec Inc Biogen Idec Inc
  3. Food and Drug Administration Food and Drug Administration
  4. See stories, photos, and quotes about Rheumatoid arthritis Rheumatoid arthritis
  5. Google Inc. Google Inc.
  6. U.S. Republican Party U.S. Republican Party

Timeline of Coverage

  1. Click to see all coverage from Oct 25, 2009
    1
    October 25, 2009
  2. Click to see all coverage from Oct 26, 2009
    7
    October 26, 2009
  3. Click to see all coverage from Oct 27, 2009
    9
    October 27, 2009
  4. Click to see all coverage from Oct 28, 2009
    36
    October 28, 2009
  5. Click to see all coverage from Oct 29, 2009
    17
    October 29, 2009
  6. Click to see all coverage from Oct 30, 2009
    8
    October 30, 2009
  7. Click to see all coverage from Oct 31, 2009
    0
    October 31, 2009
  8. Click to see all coverage from Nov 01, 2009
    0
    November 01, 2009
  9. Click to see all coverage from Nov 02, 2009
    7
    November 02, 2009
  10. Click to see all coverage from Nov 03, 2009
    13
    November 03, 2009
  11. Click to see all coverage from Nov 04, 2009
    10
    November 04, 2009
  12. Click to see all coverage from Nov 05, 2009
    4
    November 05, 2009
  13. Click to see all coverage from Nov 06, 2009
    11
    November 06, 2009
  14. Click to see all coverage from Nov 07, 2009
    3
    November 07, 2009
  15. Click to see all coverage from Nov 08, 2009
    3
    November 08, 2009
  16. Click to see all coverage from Nov 09, 2009
    7
    November 09, 2009
  17. Click to see all coverage from Nov 10, 2009
    7
    November 10, 2009
  18. Click to see all coverage from Nov 11, 2009
    6
    November 11, 2009
  19. Click to see all coverage from Nov 12, 2009
    5
    November 12, 2009
  20. Click to see all coverage from Nov 13, 2009
    9
    November 13, 2009
  21. Click to see all coverage from Nov 14, 2009
    5
    November 14, 2009
  22. Click to see all coverage from Nov 15, 2009
    35
    November 15, 2009
  23. Click to see all coverage from Nov 16, 2009
    25
    November 16, 2009
  24. Click to see all coverage from Nov 17, 2009
    27
    November 17, 2009
  25. Click to see all coverage from Nov 18, 2009
    24
    November 18, 2009
  26. Click to see all coverage from Nov 19, 2009
    19
    November 19, 2009
  27. Click to see all coverage from Nov 20, 2009
    11
    November 20, 2009
  28. Click to see all coverage from Nov 21, 2009
    3
    November 21, 2009
  29. Click to see all coverage from Nov 22, 2009
    1
    November 22, 2009
  30. Click to see all coverage from Nov 23, 2009
    10
    November 23, 2009
  31. Click to see all coverage from Nov 24, 2009
    12
    November 24, 2009
  32. Click to see all coverage from Nov 25, 2009
    13
    November 25, 2009
  33. Click to see all coverage from Nov 26, 2009
    2
    November 26, 2009
  34. Click to see all coverage from Nov 27, 2009
    1
    November 27, 2009
  35. Click to see all coverage from Nov 28, 2009
    1
    November 28, 2009
  36. Click to see all coverage from Nov 29, 2009
    2
    November 29, 2009
  37. Click to see all coverage from Nov 30, 2009
    9
    November 30, 2009
  38. Click to see all coverage from Dec 01, 2009
    10
    December 01, 2009
  39. Click to see all coverage from Dec 02, 2009
    21
    December 02, 2009
  40. Click to see all coverage from Dec 03, 2009
    10
    December 03, 2009
  41. Click to see all coverage from Dec 04, 2009
    9
    December 04, 2009
  42. Click to see all coverage from Dec 05, 2009
    2
    December 05, 2009
  43. Click to see all coverage from Dec 06, 2009
    1
    December 06, 2009
  44. Click to see all coverage from Dec 07, 2009
    23
    December 07, 2009
  45. Click to see all coverage from Dec 08, 2009
    11
    December 08, 2009
  46. Click to see all coverage from Dec 09, 2009
    21
    December 09, 2009
  47. Click to see all coverage from Dec 10, 2009
    18
    December 10, 2009
  48. Click to see all coverage from Dec 11, 2009
    2
    December 11, 2009

Related Videos

  1. YouTube
  2. Videosurf
  3. Truveo
  1. Loading video...
    1. Watch video
      Authors@Google: Anabel Stenzel & Isabel Stenzel...
      8 months ago
    2. Watch video
      Roche Bids $43.7B For Genentech - July 22
      16 months ago
    3. Watch video
      Heroes of Hope
      33 months ago
    4. Watch video
      Another Hope: Rheumatoid Arthritis Infusion The...
      13 months ago
    5. Watch video
      Popular sentiment indicators and how to use them.
      19 months ago
    6. Watch video
      FDA APPROVES HERCEPTIN® FOR THE ADJUVANT TREAT...
      21 months ago
    1. Watch video
      Heroes of Hope - Brought to you by Genentech In...
      44 months ago
    2. Watch video
      Roche Bids $43.7B For Genentech - July 22
      16 months ago
    3. Watch video
      Another Hope: Rheumatoid Arthritis Infusion The...
      13 months ago
    4. Watch video
      FDA APPROVES HERCEPTIN® FOR THE ADJUVANT TREATM...
      21 months ago
    5. Watch video
      Heroes of Hope
      33 months ago
    6. Watch video
      Popular sentiment indicators and how to use them
      19 months ago
  3. Powered by Truveo
    1. Watch video
      Return to the Doghouse
      2 days ago
    2. Watch video
      Roche's Humer Says Buying Genentech Will Boost...
      16 months ago
    3. Watch video
      Schmidt Calls Avastin Approval Important for Ge...
      21 months ago
    4. Watch video
      Analyst Porges Says Genentech May Seek Higher R...
      16 months ago
    5. Watch video
      Roche’s Schwan `Not Worried' Over Cost of Genen...
      10 months ago
    6. Watch video
      Sorrentino Says Delta-Northwest Merger `Very Ne...
      20 months ago

Related Quotes

  • Previous
  • Next
  • 1/12
  1. This is a new generation of rationally designed antibodies that bind to HER2/neu on cancer cells to an extent similar to that seen with trastuzumab (Herceptin(R), Genentech/Roche) but are distinguished from trastuzumab by their minimal targeting of HER2 on cardiac cells, which is expected to result in r...
    View articles, topics, and photos related to this quote – David Allan SOURCE: News-Medical.net 19 hours ago
  2. This is a new generation of rationally designed antibodies that bind to HER2/neu on cancer cells to an extent similar to that seen with trastuzumab (Herceptin(R), Genentech/Roche) but are distinguished from trastuzumab by their minimal targeting of HER2 on cardiac cells, which is expected to result in r...
    View articles, topics, and photos related to this quote – David Allan SOURCE: News-Medical.net 19 hours ago
  3. Genentech, a subsidiary of the Swiss drug giant Roche, estimates that 42 House members picked up some of its talking points - 22 Republicans and 20 Democrats ... Rep. Bill Pascrell Jr., a New Jersey Democrat, said: 'I regret that the language was the same. I did not know it was.'
    SOURCE: McClatchy 2 weeks ago
  4. lobbyists, employed by Genentech and by two Washington law firms, were remarkably successful in getting the statements printed in the Congressional Record under the names of different members of Congress.
    SOURCE: Sunlight Foundation 3 weeks ago
  5. Now companies like Amgen and Genentech and J & J [Johnson & Johnson] and other companies that you know are doing their logistics work right here from Louisville ... In fact, Genentech, the first investment made outside of the state of California was right here in Louisville and it was right here because...
    SOURCE: WFPL 1 month ago
  6. Now companies like Amgen and Genentech and J & J [Johnson & Johnson] and other companies that you know are doing their logistics work right here from Louisville ... In fact, Genentech, the first investment made outside of the state of California was right here in Louisville and it was right here because...
    SOURCE: WFPL 1 month ago
  7. Peregrine's bavituximab and Cotara products represent the kind of innovation that made my drug development work so exciting and fulfilling at Genentech
    SOURCE: Freshnews.com 1 month ago
  8. The Center and Genentech, Inc. are delighted to recognize Nancy for all that she has done for HDMA and for the community
    SOURCE: Medical News Today 1 month ago
  9. Even with our enterprise business, which we’ve been working hard on for some time, not only is our business accelerating, but I actually personally spoke to a number of our customers, for example, Motorola, Genentech, and Johnson Diversity, getting feedback very strong
    Eric E. Schmidt – Eric E. Schmidt SOURCE: The New York Times 1 month ago
  10. If you want a person who always plays it safe, probably they should not work for Genentech
    SOURCE: FiercePharma 1 month ago
  11. We are disappointed that the interim analysis of the phase IIb clinical trial resulted in discontinuation of the study, especially given the unmet medical need for DLBCL patients ... In collaboration with Genentech, we will conduct a detailed analysis of data from the SeaGen MARINER trial.
    SOURCE: Xconomy 2 months ago
  12. Google Inc Chief Executive Eric Schmidt said former Genentech CEO Arthur Levinson should stay on the boards of both Google and Apple Inc, despite regulatory scrutiny
    SOURCE: MacDailyNews 2 months ago